Early research (Phase 1)Study completedNCT00002196What this trial is testingCI-1012 in HIV-Infected PatientsWho this might be right forHIV Infections Parke-Davis 32
Not applicableActive Not RecruitingNCT06762470What this trial is testingPrognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal CarcinomaWho this might be right forHistopathological Diagnosis of Nasopharyngeal CarcinomaPatients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition Jiangxi Provincial Cancer Hospital 325
Early research (Phase 1)Ended earlyNCT00058773What this trial is testingGiving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin DiseaseWho this might be right forHodgkin DiseaseNon-Hodgkins Lymphoma Baylor College of Medicine 5
Not applicableStudy completedNCT05746845What this trial is testingImplication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple SclerosisWho this might be right forHealthyMultiple Sclerosis Centre Hospitalier Régional d'Orléans 100
Testing effectiveness (Phase 2)Looking for participantsNCT03266627What this trial is testingAdenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus InfectionWho this might be right forAdenovirusPrimary Immune Deficiency Disorder New York Medical College 20
Not applicableStudy completedNCT00106795What this trial is testingRelationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDSWho this might be right forHIV InfectionsFatigueHIV Positive+3 more National Institute of Allergy and Infectious Diseases (NIAID) 82
Testing effectiveness (Phase 2)Study completedNCT01734850What this trial is testingSafety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 InfectionWho this might be right forHuman Immunodeficiency Virus Calimmune, Inc. 13
Not applicableNot Yet RecruitingNCT07773597What this trial is testingPrognostic Value Enhancement Of Sequential Organ Failure Assessment )SOFA( Score by Neutrophil-Lymphocyte Ratio and Red Cell Distribution Width in Cardiogenic Shock Patients.Who this might be right forCardiogenic Shock Sohag University 150
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Not applicableStudy completedNCT01715077What this trial is testingStudy of Ipilimumab in the Immune SystemWho this might be right forPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma University Health Network, Toronto 4
Testing effectiveness (Phase 2)Study completedNCT01290692What this trial is testingStudy To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV GliomaWho this might be right forGrade IV GliomaGrade IV AstrocytomaGlioblastoma Multiforme TVAX Biomedical 14
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00150111What this trial is testingRituximab in the Treatment of Graves' DiseaseWho this might be right forGraves´ DiseaseThyroid Associated Ophthalmopathy Odense University Hospital 20
Early research (Phase 1)Temporarily pausedNCT06792344What this trial is testingClinical Study of CD19 CAR-T in the Treatment of Refractory Systemic SclerosisWho this might be right forSystemic Sclerosis (SSc) The Children's Hospital of Zhejiang University School of Medicine 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02690545What this trial is testingStudy of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHLWho this might be right forLymphomaLymphoma, Non-HodgkinImmune System Diseases+5 more UNC Lineberger Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT01386619What this trial is testingNK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)Who this might be right forLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more University Hospital, Basel, Switzerland 15
Not applicableStudy completedNCT00000900What this trial is testingThe Effects of Illnesses on HIV Levels in the BodyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202What this trial is testingBrentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin LymphomaWho this might be right forAnn Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more City of Hope Medical Center 155
Not applicableActive Not RecruitingNCT05524012What this trial is testingLongitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal CancerWho this might be right forLocally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more Jena University Hospital 40
Early research (Phase 1)Study completedNCT00000645What this trial is testingA Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 LymphocytesWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 32